[医药卫生]原发性肝癌的治疗现状.ppt

原发性肝癌的治疗现状;原发性肝癌的流行病学;原发性肝癌的流行病学;中国十大恶性肿瘤致死率;肺癌 2964 肝癌 2664 食道癌 2553 胃癌 2352 结直肠癌 873 白血病 355 乳腺癌 224 鼻咽癌 144 膀胱癌 112 宫颈癌 71 合计 14229;原发性肝癌的主要危险因素;Global Distribution：HBV carrier state and hepatocellular Carcinoma;HBV, HCV INDUCE HCC MECANISM;HBV, HCV INDUCE HCC MECANISM;原发性肝癌的治疗;原发性肝癌的外科治疗;手术切除指针: 1, Child –Pugh A or upper end of Grade B 2, 病灶位于一个肝叶,单灶5cm,多灶不超个3个 3, 切除体积不超个2/3肝叶;原发性肝癌肝移植指针;Child –Pugh Classification System;肝癌术后预后因素;肝癌术后生存率;肝癌肝移植术后生存率;Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients.;Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients.;肝癌手术辅助化疗问题;Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.;Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma ;Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patientsMetaanalysis of three randomized controlled trials ;Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials;第二军医大学资料;原发性肝癌术后预防性TACE的意义 (附433例病例随访) ;肝癌的介入治疗;肝癌介入治疗方式;经皮肝穿刺无水乙醇注射（PEI）;肝动脉化疗栓塞(TACE);肝动脉灌注治疗（HAI）;肝癌的射频消融（RFA）;肝癌的冷冻消融（CYA）;TACE:是否确能延长存活时间?;TACE治疗后存活期;TACE及PEIT;Surgical Resection Versus Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma on Cirrhotic Liver.;Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma: A Prospective Study.;A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma.;肝癌的内科治疗;肝癌的内科治疗模式;肝癌的内科治疗;HCC的联合化疗方案：;肝癌的内科治疗;Single Agent Phase II Data for HCC;Single Agent Gemcitabine Data;Gem/Cis (GAP) for HCC - USA;Single Agent Gemzar Data for HCC;Gemcitabine hepatic arte